Key Benefits

• Schizonticidal as a single dose.
  
  
• Novel mode of action making Malafin effective against some strains of Plasmodium falciparum resistant to other antimalarials
  
  

Indications

For areas where

• chloroquine resistance is widespread.
  
  
• resistance to other antimalarials such as proguanil, pyrimethamine and sulfadoxine/pyrimethamine combinations has been reported
  
  

Key Benefits

• Triple combination has been shown to delay emergence of resistance in rodent malaria models

Key Benefits

For areas where

• 4-aminoquinoline antimalarial agent with mode of action similar to that of chloroquine
  
  
• As effective as chloroquine against chloroquine-sensitive strains of Plasmodium falciparum
  
  
• Also effective against some chloroquine resistant strains